Trials / Completed
CompletedNCT00393003
Target-controlled Infusion of Propofol and Remifentanil for Postoperative Sedation Guided by the Bispectral Index
Target-controlled Infusion of Propofol and Remifentanil for Postoperative Sedation Guided by the Bispectral Index: Comparison Between Manual Perfusion and Automated Perfusion
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 32 (planned)
- Sponsor
- Hopital Foch · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective randomized study evaluates the effectiveness of a closed-loop anesthesia system during the postoperative period.
Detailed description
The Bispectral Index (BIS) is an electroencephalogram-derived measure of anesthetic depth. A closed-loop anesthesia system can be built using BIS as the control variable, two proportional-integral-differential control algorithms, a propofol and a remifentanil target-controlled infusion systems as the control actuators. Preliminary results show that this system can be used during surgery. We propose a prospective randomized study to evaluate the effectiveness of such a closed-loop anesthesia system during the postoperative period. Two groups of patients are compared: one in which propofol and remifentanil are administered by the anesthesiologist using target-controlled infusion systems, and one in which propofol and remifentanil are administered automatically by the combined closed-loop anesthesia system. In both groups, the goal is to maintain BIS between 40 and 60, the recommended range during anesthesia by the manufacturer. We expect the combined closed-loop system group to do similar or better.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Closed-loop anesthesia system |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2007-04-01
- Completion
- 2007-04-01
- First posted
- 2006-10-26
- Last updated
- 2009-08-31
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00393003. Inclusion in this directory is not an endorsement.